This inventor holds 1 USPTO granted patent. Top assignee: St Pharm Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Hyeon Jin Lee: Innovator in Pharmaceutical Chemistry
Introduction
Hyeon Jin Lee is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative methods in drug preparation. His work is characterized by a commitment to advancing medical science and improving therapeutic options.
Latest Patents
Hyeon Jin Lee holds a patent for a novel method titled "Method for preparation of (S)-N1-(2-aminoethyl)-3-(4-alkoxyphenyl)propane-1,2-diamine trihydrochloride." This invention relates to an efficient process for synthesizing a compound that has potential applications in various therapeutic areas. The patent showcases his expertise and dedication to enhancing pharmaceutical formulations.
Career Highlights
Throughout his career, Hyeon Jin Lee has been associated with St Pharm Co., Ltd., where he has played a crucial role in research and development. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in the pharmaceutical industry. His innovative approach has led to advancements that benefit both the company and the broader medical community.
Collaborations
Hyeon Jin Lee has collaborated with talented professionals in his field, including Hyun Woo Baek and Sang Kyu Kang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research and development efforts.
Conclusion
Hyeon Jin Lee is a distinguished inventor whose contributions to pharmaceutical chemistry are noteworthy. His innovative methods and collaborative spirit continue to drive advancements in the industry. His work exemplifies the impact of dedicated inventors on the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
